BioRem (CVE:BRM) Hits New 52-Week High – Should You Buy?

Shares of BioRem Inc. (CVE:BRM) hit a new 52-week high during trading on Thursday. The stock traded as high as C$4.46 and last traded at C$4.27, with a volume of 25,080 shares. The stock had previously closed at C$4.44.

BioRem Stock Performance

The firm has a market cap of C$70.01 million, a price-to-earnings ratio of 12.86 and a beta of 0.77. The company has a current ratio of 2.04, a quick ratio of 1.08 and a debt-to-equity ratio of 14.17. The stock’s 50 day moving average is C$3.60 and its 200 day moving average is C$3.12.

Insider Transactions at BioRem

In other news, Director Derek Webb sold 28,700 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of C$3.82, for a total transaction of C$109,634.00. Following the completion of the sale, the director owned 362,370 shares in the company, valued at C$1,384,253.40. The trade was a 7.34% decrease in their ownership of the stock. 1.90% of the stock is owned by company insiders.

BioRem Company Profile

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.